1. Home
  2. VERU vs SKIL Comparison

VERU vs SKIL Comparison

Compare VERU & SKIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.99

Market Cap

48.2M

Sector

Health Care

ML Signal

HOLD

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$6.64

Market Cap

40.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERU
SKIL
Founded
1971
1998
Country
United States
United States
Employees
N/A
2247
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
40.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
VERU
SKIL
Price
$2.99
$6.64
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
5.2M
93.6K
Earning Date
05-12-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,296,958.00
N/A
Revenue This Year
N/A
$0.11
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$3.43
52 Week High
$7.33
$18.45

Technical Indicators

Market Signals
Indicator
VERU
SKIL
Relative Strength Index (RSI) 54.10 47.93
Support Level $2.11 $6.30
Resistance Level $4.57 $8.36
Average True Range (ATR) 0.25 0.88
MACD -0.03 0.01
Stochastic Oscillator 28.68 53.76

Price Performance

Historical Comparison
VERU
SKIL

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

Share on Social Networks: